These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9875416)

  • 1. Structure-activity relationship of fluoroquinolone in Escherichia coli.
    Lee S; Park T; Lee Y
    Arch Pharm Res; 1998 Apr; 21(2):106-12. PubMed ID: 9875416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction.
    Cohen SP; McMurry LM; Hooper DC; Wolfson JS; Levy SB
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1318-25. PubMed ID: 2679373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
    Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
    J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of clinical resistance to fluoroquinolones in Enterococcus faecalis.
    Nakanishi N; Yoshida S; Wakebe H; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1053-9. PubMed ID: 1656852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid.
    Moniot-Ville N; Guibert J; Moreau N; Acar JF; Collatz E; Gutmann L
    Antimicrob Agents Chemother; 1991 Mar; 35(3):519-23. PubMed ID: 2039202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates.
    Tavío MM; Vila J; Ruiz J; Ruiz J; Martín-Sánchez AM; Jiménez de Anta MT
    J Antimicrob Chemother; 1999 Dec; 44(6):735-42. PubMed ID: 10590273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of quinolone resistance in clinical isolates: accumulation of sparfloxacin and of fluoroquinolones of various hydrophobicity, and analysis of membrane composition.
    Denis A; Moreau NJ
    J Antimicrob Chemother; 1993 Sep; 32(3):379-92. PubMed ID: 8262860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance.
    Zhao X; Xu C; Domagala J; Drlica K
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13991-6. PubMed ID: 9391140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of ciprofloxacin and lomefloxacinin fluoroquinolone-resistant strains of Escherichia coli.
    Xia P; Feng P; Zhong L; Lu X; Lei B
    Chin Med J (Engl); 2002 Jan; 115(1):31-5. PubMed ID: 11930654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the AcrAB-TolC efflux pump to high-level fluoroquinolone resistance in Escherichia coli isolated from dogs and humans.
    Sato T; Yokota S; Okubo T; Ishihara K; Ueno H; Muramatsu Y; Fujii N; Tamura Y
    J Vet Med Sci; 2013 May; 75(4):407-14. PubMed ID: 23149545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the accumulation of fluoroquinolones in clinical isolates of susceptible and multi-drug-resistant Escherichia coli strains].
    Fang ZP; Xu W; Liu XK; Song XH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):86-9. PubMed ID: 15702790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro activity of moxifloxacin against fluoroquinolone-resistant strains of aerobic gram-negative bacilli and Enterococcus faecalis.
    Tankovic J; Bachoual R; Ouabdesselam S; Boudjadja A; Soussy CJ
    J Antimicrob Chemother; 1999 May; 43 Suppl B():19-23. PubMed ID: 10382871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates.
    Becnel Boyd L; Maynard MJ; Morgan-Linnell SK; Horton LB; Sucgang R; Hamill RJ; Jimenez JR; Versalovic J; Steffen D; Zechiedrich L
    Antimicrob Agents Chemother; 2009 Jan; 53(1):229-34. PubMed ID: 18838594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoroquinolone action against mycobacteria: effects of C-8 substituents on growth, survival, and resistance.
    Dong Y; Xu C; Zhao X; Domagala J; Drlica K
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2978-84. PubMed ID: 9797236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli.
    Oethinger M; Kern WV; Goldman JD; Levy SB
    J Antimicrob Chemother; 1998 Jan; 41(1):111-4. PubMed ID: 9511045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The frequency of in vitro resistance to fluoroquinolones among clinical isolates of Escherichia coli.
    Poiată A; Bădicuţ I; Grigore L; Buiuc D
    Roum Arch Microbiol Immunol; 2000; 59(1-2):63-9. PubMed ID: 11845477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolone resistance among methicillin-resistant staphylococci after usage of fluoroquinolones other than ciprofloxacin in Taiwan.
    Chang SC; Hsieh WC; Luh KT
    Diagn Microbiol Infect Dis; 1994 Jul; 19(3):143-7. PubMed ID: 7820993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolone action in mycobacteria: similarity with effects in Escherichia coli and detection by cell lysate viscosity.
    Drlica K; Xu C; Wang JY; Burger RM; Malik M
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1594-9. PubMed ID: 8807046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.
    Yokota S; Sato T; Okubo T; Ohkoshi Y; Okabayashi T; Kuwahara O; Tamura Y; Fujii N
    Chemotherapy; 2012; 58(1):52-9. PubMed ID: 22343392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of high-level fluoroquinolone resistance in Escherichia coli O78:K80 isolated from turkeys.
    Giraud E; Leroy-Sétrin S; Flaujac G; Cloeckaert A; Dho-Moulin M; Chaslus-Dancla E
    J Antimicrob Chemother; 2001 Mar; 47(3):341-3. PubMed ID: 11222567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.